Get the Stockscreener App
22.43
1.72%
0.38
10 X Genomics Inc stock is traded at $22.43, with a volume of 2.42M.
It is up +1.72% in the last 24 hours and up +1.72% over the past month.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
See More
Previous Close:
$22.05
Open:
$22.05
24h Volume:
2.42M
Relative Volume:
0.96
Market Cap:
$2.89B
Revenue:
$642.82M
Net Income/Loss:
$-43.54M
P/E Ratio:
-64.16
EPS:
-0.3496
Net Cash Flow:
$130.12M
1W Performance:
+1.59%
1M Performance:
+1.72%
6M Performance:
+64.44%
1Y Performance:
+176.91%
1-Day Range:
$21.46
$22.73
1-Week Range:
$19.53
$23.44
52-Week Range:
$7.72
$26.45
10 X Genomics Inc Stock (TXG) Company Profile
Name
10 X Genomics Inc
Sector
Industry
Phone
(925) 401-7300
Address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
22.43 | 2.89B | 642.82M | -43.54M | 130.12M | -0.3496 |
VEEV
Veeva Systems Inc
|
171.60 | 28.03B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
52.58 | 10.16B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
55.00 | 9.87B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.40 | 6.96B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
24.98 | 4.61B | 637.78M | 239.40M | 307.21M | 1.1909 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-11-25 | Initiated | Piper Sandler | Neutral |
| Feb-13-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-22-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-18-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-10-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-25-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-03-24 | Resumed | Jefferies | Hold |
| May-01-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-10-23 | Initiated | Barclays | Overweight |
| Mar-31-23 | Initiated | Stephens | Overweight |
| Feb-02-23 | Initiated | UBS | Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Aug-18-22 | Downgrade | Goldman | Neutral → Sell |
| Jul-25-22 | Initiated | Canaccord Genuity | Buy |
| Jul-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-15-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-14-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-15-21 | Initiated | William Blair | Outperform |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Overweight |
| Jul-10-20 | Initiated | Stifel | Buy |
| Mar-05-20 | Initiated | Guggenheim | Buy |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-07-19 | Initiated | BofA/Merrill | Buy |
| Oct-07-19 | Initiated | Cowen | Outperform |
| Oct-07-19 | Initiated | JP Morgan | Overweight |
| Sep-24-19 | Initiated | Evercore ISI | Outperform |
View All
10 X Genomics Inc Stock (TXG) Latest News
M&T Bank Corp Has $1.19 Million Stake in 10x Genomics $TXG - MarketBeat
10x Genomics (TXG) price target increased by 12.41% to 23.75 - MSN
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
TXG Price Today: 10x Genomics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
10X Genomics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Price, Trades & News - GuruFocus
Q3 2025 10X Genomics Inc Earnings Call Transcript - GuruFocus
10x Genomics Inc Stock Intrinsic Values | HAM:1KJ - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
10x Genomics Inc Stock Warning Signs | HAM:1KJ - GuruFocus
10x Genomics Inc Stock Operating Data - GuruFocus
10x Genomics Inc (HAM:1KJ) Valuation: Fairly Valued - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Price & 30 Year Financial Data - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Earnings Transcripts - GuruFocus
10x Genomics Inc (HAM:1KJ) Competitors 2026 - GuruFocus
10x Genomics Inc (HAM:1KJ) DCF Valuation - GuruFocus
10x Genomics Inc (HAM:1KJ)Valuation Measures & Financial Statistics - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock News, Headlines & Updates - GuruFocus
TXG Stock Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
Vanguard holds 6.17M shares of 10X Genomics (NASDAQ: TXG), 5.24% stake - Stock Titan
10x Genomics investors can watch management at a May 13 BofA chat - Stock Titan
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - Barchart
10x Genomics (NASDAQ:TXG) Trading Down 8%What's Next? - MarketBeat
10x Genomics joins a 100,000-patient tissue atlas across 3 continents - Stock Titan
MSN Money - MSN
TXG Stock Price, Quote & Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
Vanguard Portfolio Management reports 6.98M TXG shares (NASDAQ: TXG) - Stock Titan
10x Genomics seen as key player in AI-driven biological data buildout - MSN
10x Genomics (TXG) details 2026 virtual meeting, director votes and Say on Pay - Stock Titan
Why 10x Genomics (TXG) Shares Are Trading Lower Today - Yahoo Finance
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - MSN
TXG Financials: Income Statement, Balance Sheet & Cash Flow | 10X Genomics, Inc. - Stock Titan
10X Genomics Hits New 52-Week High at $25.69, Showcasing Market Resilience - Markets Mojo
10X Genomics Experiences Evaluation Revision Amid Strong Market Performance and Volatility - Markets Mojo
10x Genomics introduces Atera at AACR 2026 - SelectScience
10X Genomics Hits New 52-Week High of $26.44, Reflecting Strong Growth - Markets Mojo
10x Genomics (NASDAQ:TXG) Reaches New 1-Year HighHere's What Happened - MarketBeat
10x Genomics Stock Up on Atera Launch, Spatial Biology Scale Enhanced - Yahoo Finance
Bayforest Capital Ltd Has $286,000 Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Price Target Raised to $30.00 - MarketBeat
10x Genomics (NASDAQ:TXG) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
10x Genomics (TXG) Launches Atera: A Breakthrough in Spatial Bio - GuruFocus
10x Genomics, Inc.Common Stock (NQ: TXG - The Chronicle-Journal
10x Genomics Launches Atera Platform for Spatial Biology - Intellectia AI
10x opens Atera pre-orders for cell-by-cell mapping across whole tissues - Stock Titan
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood - ChartMill
10X Genomics Opens with 6.32% Gain, Outperforming S&P 500's 2.51% Increase - Markets Mojo
Best Genomics Stocks for 2026 and How to Invest - The Motley Fool
10X Genomics stock hits 52-week high at 26.07 USD By Investing.com - Investing.com India
10x Genomics Introduces Atera Platform - marketscreener.com
10X Genomics stock hits 52-week high at 26.07 USD - Investing.com
10 X Genomics Inc Stock (TXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
10 X Genomics Inc Stock (TXG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Saxonov Serge | Chief Executive Officer |
Mar 23 '26 |
Sale |
19.13 |
10,000 |
191,297 |
1,177,273 |
| Saxonov Serge | Chief Executive Officer |
Mar 24 '26 |
Sale |
19.52 |
5,000 |
97,612 |
1,172,273 |
| Saxonov Serge | Chief Executive Officer |
Mar 02 '26 |
Sale |
22.73 |
16,152 |
367,097 |
1,203,667 |
0.00%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):